Workflow
金凯生科: 中信建投证券股份有限公司关于金凯(辽宁)生命科技股份有限公司2025年上半年度跟踪报告
Zheng Quan Zhi Xing·2025-08-22 16:16

Group 1 - The report indicates that the company JinKai (Liaoning) Life Science Co., Ltd. has been compliant with information disclosure requirements, with no instances of delayed reviews [1] - The company has established and effectively executed internal regulations to prevent resource occupation by related parties and manage fundraising [1] - The company has conducted monthly checks on its fundraising special accounts, ensuring that project progress aligns with disclosed information [1] Group 2 - The report highlights a slow progress in the investment of fundraising projects, primarily due to changes in international trade policies and market conditions for innovative drugs [3] - There are no reported issues regarding external investments, risk investments, or financial assistance [3] - The company and its shareholders have fulfilled their commitments, with no unfulfilled commitments reported [3]